Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients

Clinical and Experimental Immunology

Volumn 131, Issue 1, 2003, Pages 174-181

  Sadallah, Salima ^a   Hess, C ^a   Trendelenburg, M ^a   Vedeler, C ^b   Lopez Trascasa, M ^c   Schifferli, J A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERGEN   (Norway)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

AntiC1q; AntiCR1; Auto antibody; HIV; SLE

Indexed keywords

ALLOANTIBODY; ANTIBODY; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3B RECEPTOR ANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; RECOMBINANT ANTIGEN; SEPHAROSE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ALLERGIC GLOMERULONEPHRITIS; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BLOOD DONOR; BLOOD GROUP AB; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INHIBITION KINETICS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; MYELOMA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING;

AUTOANTIBODIES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV-1; HUMANS; LIVER CIRRHOSIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, COMPLEMENT 3B;

EID: 0037234707     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02045.x     Document Type: Article

References (33)

1. Nelson RA. The immune adherence phenomenon, an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science 1953; 118:733.
2. Krych M, Hauhart R, Atkinson JP. Structure-function analysis of the active sites of complement receptor type 1. J Biol Chem 1998; 273:8623-9.
3. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leucocyte, B lymphocyte, and monocyte. J Exp Med 1980; 152:20-30.
4. Fearon D, Ahearn JM. Complement receptor type 1 (C3b/C4b receptor; CD 35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21). In: Lambris JD, eds. Current Topics in Microbiology and Immunology (the Third Component of Complement). Berlin: Springer Verlag, 1989; 153:83-98.
5. Kazatchkine MD, Fearon DT. Deficiencies of human complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodef Rev 1990; 2:17-41.
6. Paccaud JP, Carpentier JL, Schifferli JA. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane. J Immunol 1988; 141:3889-94.
7. Iida K, Mornaghi R, Nussenzweig V. Complement receptor (CR) deficiency in erythrocytes from the patients with systemic lupus erythematosus. J Exp Med 1981; 155:1427-38.
8. Tausk FA, McCutchan A, Spechko P, Schreiber RD, Gigli I. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 1986; 78:977-82.
9. Kanto T, Hayashi N, Takehara T et al. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients. J Med Virol 1996; 50:126-34.
10. Moldenhauer F, Botto M, Walport MJ. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: No correlation with structural or numerical polymorphisms. Clin Exp Immunol 1988; 72:74-8.
11. Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ. Family studies of erythrocyte complement receptor type 1 levels: Reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 1985; 59:547-54.
12. Lach-Trifilieff E, Marfurt J, Schwarz S, Sadallah S, Schifferli JA. Complement receptor 1 (CD35) on human reticulocytes: Normal expression in systemic lupus erythematosus and HIV-infected patients. J Immunol 1999; 162:7549-54.
13. Davies KA, Hird V, Stewart S et al. A study of in vivo immune complex formation and clearance in man. J Immunol 1990; 144:4613-20.
14. Wilson JG, Jack RM, Wong WW, Schur PH, Fearon DT. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus. J Clin Invest 1985; 76:182-90.
15. Cook JM, Kazatchkine MD, Bourgeois P, Mignon F, Mery JP, Kahn MF. Anti-C3b-receptor (CR1) antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1986; 38:135-8.
16. Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J Exp Med 1991; 173:1159-63.
17. Moulds JM, Zimmerman PA, Doumbo OK et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001; 97:2879-85.
18. Sadallah S, Gudat F, Laissue JA, Spath PJ, Schifferli JA. Glomerulonephritis in a patient with complement factor I deficiency. Am J Kidney Dis 1999; 33:1153-7.
19. Yazdanbakhsh K, Oyen R, Yu Q et al. High-level, stable expression of blood group antigens in a heterologous system. Am J Hematol 2000; 63:114-24.
20. Sadallah S, Lach E, Lutz HU, Schwarz S, Guerne PA, Schifferli JA. CR1, CD35 in synovial fluid from patients with inflammatory joint diseases. Arthritis Rheum 1997; 40:520-6.
21. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 1999; 42:187-8.
22. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991; 18:230-4.
23. Pascual M, Duchosal MA, Steiger G et al. Circulating soluble CR1 (CD35), serum levels in diseases and evidence for its release by human leukocytes. J Immunol 1993; 151:1702-11.
24. Nickells M, Hauhart R, Krych M et al. Mapping epitopes for 20 monoclonal antibodies to CR1 [published erratum appears in: Clin Exp Immunol 1998;113: 315]. Clin Exp Immunol 1998; 112:27-33.
25. Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion. J Immunol 1999; 163:5056-63.
26. Nilsson B, Ekdahl KN, Svarvare M, Bjelle A, Nilsson UR. Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: Implications for a regulatory function. Clin Exp Immunol 1990; 82:262-7.
27. Fries LF, Prince GM, Gaither TA, Frank MM. Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues. J Immunol 1985; 135:2673-9.
28. Martensson U, Sjoholm AG, Sturfelt G, Truedsson L, Laurell AB. Western blot analysis of human IgG reactive with the collagenous portion of C1q: Evidence of distinct binding specificities. Scand J Immunol 1992; 35:735-44.
29. Bell SA, Faust H, Schmid A, Meurer M. Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol 1998; 113:327-32.
30. Moulds JM, Moulds JJ, Brown M, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens, negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992; 62:230-5.
31. Zimmerman J, Dellinger R, Straube R, Levin J. Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome. Crit Care Med 2000; 28:3149-54.
32. Cosio FG, Shen XP, Birmingham DJ, Van Aman M, Hebert LA. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol 1990; 145:4198-206.
33. Tausk F, Gigli I. The human C3b receptor. function and role in human diseases. J Invest Dermatol 1990; 94 (Suppl.):141S-5S.